Onward Medical N.V. (FRA:63E)

Market Cap	193.04M -28.6%
Revenue (ttm)	2.72M +226.9%
Net Income	-38.65M
EPS	-0.78
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,606
Open	4.410
Previous Close	4.375
Day's Range	4.370 - 4.410
52-Week Range	3.490 - 7.180
Beta	n/a
RSI	48.70
Earnings Date	Mar 27, 2026

About Onward Medical

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people with SCI; ARCBCI, an implanted brain-computer interface to restore thought-driven movement. It operates in France, Germany, the Netherlands, the United Ki...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2014
• Employees: 103
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 63E

Financial Performance

In 2024, Onward Medical's revenue was 1.74 million, an increase of 226.88% compared to the previous year's 532,000. Losses were -35.73 million, -1.26% less than in 2023.